Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
What made us buy IEX@193, Tata Power@56, Titan@330, Divis@629, Persistent@700.

Adi Rasayan informs about rectified outcome of board meeting

29 Sep 2015

With reference to the earlier annoucement dated September 28, 2015, regarding Oucome of Board Meeting, Adi Rasayan has now informed that the Board of Directors at their meeting held on September 28, 2015, have subject to the approval of the Hon’ble High Court, shareholders. Stock Exchanges where the shares of the Company are listed and other relevant regulatory authorities approved the reduction of Equity Share Capital of the Company from Rs 6,51,97,000  divided into 65,19,700 Equity Shares of Rs 10 each fully paid-up to Rs 32,59,850 divided in to 3,25,985 Equity Shares of Rs 10 each fully paid up and such reduction be effected by canceling Rs 10 per share on 61,93,715 Equity Shares amounting to Rs 6,19,37,150 in the existing paid up Equity Share Capital against debit balance in Profit and Loss account. The Board of Directors has also decided to appoint advisors/consultants for Valuation Report, Fairness opinion and other relevant matters.

The above information is a part of company’s filings submitted to BSE.

Related Genpharmasec Ltd. Links:

Genpharmasec Share Price

6.46 -0.05 (-0.77%) Dec 03, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sudarshan Chemicals 579.40
Bodal Chemicals 110.20
Kiri Industries 456.30
Bhageria Industries 257.05
Shree Pushkar Chem 210.65
View more..
Sensex vs Genpharmasec
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback